http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1632484-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b9036c33bbe3f4ea428655b76200f7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_268be9afa00cf55b5aa72b1612151ecb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-135
filingDate 2004-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a8d89d73e0dace8525f6eefb1436ced
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73cd8c6e722eca7b894624bdb8d0a596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be15999698ae42962b1157ec62aaa425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c98bf780c8da0d6053f8dcfe42bbcfac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1024e6bf91042db8bd77fb4760cb1ba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5bbeb8b8b8bfeefe1beb8b9ce63e52f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_564a81e31586379372c50829cce0dc5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d33fad75da83e46caadf75bf07a9c51
publicationDate 2008-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1632484-A4
titleOfInvention D RIV OF THIADIAZOLINE
abstract Disclosed are thiadiazoline derivatives represented by the general formula (I): (I) [wherein R1 represents a hydrogen atom or the like; R2 represents a hydrogen atom, -COR5 (wherein R5 represents a lower alkyl, etc.) or the like; R3 represents a lower alkyl or the like; R4 represents an aryl or the like; A represents -(CH2)n- (wherein n is an integer of 1-6) or the like; and B represents -NR6R7 (wherein R6 and R7 may be the same or different and represent hydrogen atoms, lower alkyls, etc.) or the like] and pharmacologically acceptable salts thereof.
priorityDate 2003-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1616866-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 25.